| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 1.57 | -0.01 (-0.40%) | 1.34 - 2.09 | 24.0 thousand (Below Avg) |
Market data as of 12:46PM 06/17/13. Quotes are delayed by at least 15 min.
| Open | 1.58 |
|---|---|
| Previous Close | 1.58 |
| Day's Range | 1.57 - 1.59 |
| Market Cap | 34.2M |
| Avg Volume (10 Day) | 33.3K |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | -0.03 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Neutral |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Neutral |
| Borrows within reasonable limits? | Fail |
| Stock is undervalued? | Fail |
| Have investors caught on? | Pass |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Pass |
No news headlines available for INFU
| INFU | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 5.63% | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | 0.70 | |
| LT Debt/Equity | 0.61 | |
| Earnings Yield | -- | |
| Price/Sales | 0.58 |
| Company | Last | Change |
|---|---|---|
| ERBA Diagnostics Inc | 0.79 | +1.28% |
| Retractable Technologies Inc | 1.41 | +1.44% |
| MELA Sciences Inc | 0.85 | -4.83% |
| Daxor Corp | 7.30 | 0.00% |
| Kips Bay Medical Inc | 1.02 | -4.67% |
Data is delayed by at least 15 min.